Linical Co., Ltd.   Report issue

For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Seoul Korea, Republic of (2005)

Organization Overview

First Clinical Trial
2015
NCT02415959
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Linical Co., Ltd. | Linical Korea

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 3)

Cystic Fibrosis (Phase 2)

Diabetes Mellitus (Phase 4)

Exocrine Pancreatic Insufficiency (Phase 2)

Fibrosis (Phase 2)

Hypercholesterolemia (Phase 4)

Metabolic Syndrome (Phase 4)

Rhinitis (Phase 3)

Rhinitis, Allergic (Phase 3)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 31
  • # of Trial APIs: 40